CN102321185B - 一种中分子量羟乙基淀粉的合成方法 - Google Patents
一种中分子量羟乙基淀粉的合成方法 Download PDFInfo
- Publication number
- CN102321185B CN102321185B CN 201110226792 CN201110226792A CN102321185B CN 102321185 B CN102321185 B CN 102321185B CN 201110226792 CN201110226792 CN 201110226792 CN 201110226792 A CN201110226792 A CN 201110226792A CN 102321185 B CN102321185 B CN 102321185B
- Authority
- CN
- China
- Prior art keywords
- hydroxyethyl
- reaction
- molecular weight
- waxy corn
- corn starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001612 Hydroxyethyl starch Polymers 0.000 title claims abstract description 25
- 229940050526 hydroxyethylstarch Drugs 0.000 title claims abstract description 21
- 238000001308 synthesis method Methods 0.000 title abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 41
- 229920002261 Corn starch Polymers 0.000 claims abstract description 27
- 239000008120 corn starch Substances 0.000 claims abstract description 27
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 claims abstract description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 13
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 238000006467 substitution reaction Methods 0.000 claims abstract description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical group OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 4
- 239000008213 purified water Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 2
- 239000011261 inert gas Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 26
- 239000003814 drug Substances 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000008346 aqueous phase Substances 0.000 abstract description 4
- 239000006227 byproduct Substances 0.000 abstract description 4
- -1 cyclochloroethane Chemical compound 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 239000000376 reactant Substances 0.000 abstract description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 2
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 239000003058 plasma substitute Substances 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000002016 colloidosmotic effect Effects 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000004768 organ dysfunction Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- LGGXTTVQTBPPLC-ULAWRXDQSA-N (4r,5s,6r,7r)-1,4,5,6,7,8-hexahydroxyoctan-3-one Chemical group OCCC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO LGGXTTVQTBPPLC-ULAWRXDQSA-N 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- ULELCQYQCBHXFY-UHFFFAOYSA-N CNCCC1CC1 Chemical compound CNCCC1CC1 ULELCQYQCBHXFY-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000000454 anti-cipatory effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000003746 solid phase reaction Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110226792 CN102321185B (zh) | 2011-08-09 | 2011-08-09 | 一种中分子量羟乙基淀粉的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110226792 CN102321185B (zh) | 2011-08-09 | 2011-08-09 | 一种中分子量羟乙基淀粉的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102321185A CN102321185A (zh) | 2012-01-18 |
CN102321185B true CN102321185B (zh) | 2012-12-19 |
Family
ID=45449040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110226792 Active CN102321185B (zh) | 2011-08-09 | 2011-08-09 | 一种中分子量羟乙基淀粉的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102321185B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102617744B (zh) * | 2012-04-07 | 2013-09-25 | 山东齐都药业有限公司 | 一种窄分布中分子量羟乙基淀粉的制备方法 |
CN102659953B (zh) * | 2012-04-18 | 2016-01-20 | 高旭 | 一种分子量为550万的羟乙基淀粉的制备方法 |
CN102766219B (zh) * | 2012-05-23 | 2014-08-13 | 山东齐都药业有限公司 | 一种降低中分子量羟乙基淀粉双取代比例的制备工艺 |
CN102675477B (zh) * | 2012-05-24 | 2013-10-09 | 河北科技大学 | 一种提高中分子量羟乙基淀粉收率的制备方法 |
CN103087206B (zh) * | 2013-02-20 | 2015-09-30 | 郑桂富 | 可用作代血浆的羟乙基淀粉200/0.5及其制备方法 |
CN103897070B (zh) * | 2014-04-21 | 2016-03-09 | 河北科技大学 | 一种以离子液体为反应介质的羟乙基淀粉130/0.4的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2837067A1 (de) * | 1977-11-14 | 1979-05-17 | Kyorin Seiyaku Kk | Verfahren zur herstellung von hydroxyaethylstaerke |
DE19808079A1 (de) * | 1998-02-20 | 1999-08-26 | Schering Ag | Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
DE10105921A1 (de) * | 2001-02-09 | 2002-08-14 | Braun Melsungen Ag | An Kolloide gebundene Arzneiwirkstoffe |
CN1625569A (zh) * | 2002-02-20 | 2005-06-08 | 德国费森尤斯卡比有限公司 | 淀粉衍生物、淀粉活性物质结合物、其制备方法及其作为药物的应用 |
CN1926155A (zh) * | 2004-03-01 | 2007-03-07 | B·布朗·梅尔松根有限公司 | 羟乙基淀粉 |
CN102086234A (zh) * | 2009-12-07 | 2011-06-08 | 重庆大新药业股份有限公司 | 一种提高中分子量羟乙基淀粉质量的制备方法 |
-
2011
- 2011-08-09 CN CN 201110226792 patent/CN102321185B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2837067A1 (de) * | 1977-11-14 | 1979-05-17 | Kyorin Seiyaku Kk | Verfahren zur herstellung von hydroxyaethylstaerke |
DE19808079A1 (de) * | 1998-02-20 | 1999-08-26 | Schering Ag | Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
DE10105921A1 (de) * | 2001-02-09 | 2002-08-14 | Braun Melsungen Ag | An Kolloide gebundene Arzneiwirkstoffe |
CN1625569A (zh) * | 2002-02-20 | 2005-06-08 | 德国费森尤斯卡比有限公司 | 淀粉衍生物、淀粉活性物质结合物、其制备方法及其作为药物的应用 |
CN1926155A (zh) * | 2004-03-01 | 2007-03-07 | B·布朗·梅尔松根有限公司 | 羟乙基淀粉 |
CN102086234A (zh) * | 2009-12-07 | 2011-06-08 | 重庆大新药业股份有限公司 | 一种提高中分子量羟乙基淀粉质量的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102321185A (zh) | 2012-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102321185B (zh) | 一种中分子量羟乙基淀粉的合成方法 | |
CN102161752B (zh) | 肌酐催化乳酸缩聚合成医用生物降解性聚乳酸的工艺方法 | |
CN103694376B (zh) | 一种制备磺丁基醚-β-环糊精的方法 | |
CN102040675B (zh) | 一种羟丙基-β-环糊精的制备方法 | |
AU2004272255A1 (en) | Method for the production of 4-(4-aminophenyl)-3-morpholinon | |
CN101100440A (zh) | 一种抗肿瘤药物美法仑的合成工艺 | |
CN106699756A (zh) | β内酰胺酶抑制剂阿维巴坦的合成方法 | |
CN101575354A (zh) | 阿贝卡星及其中间体地贝卡星的合成方法 | |
CN101492380B (zh) | 米格列醇关键中间体的制备方法 | |
CN100535015C (zh) | 醛糖酸酯、制备醛糖酸酯的方法和制备在游离氨基上与多糖或多糖衍生物偶联的药学活性成分的方法 | |
CN101829338A (zh) | 基于巯嘌呤类药物的新型两亲性大分子前药及其制备方法 | |
WO2019193608A1 (en) | Improved process for the preparation of iron (iii) carboxymaltose | |
CN101591428A (zh) | 一种聚酯树枝状大分子的制备方法 | |
CN102766219B (zh) | 一种降低中分子量羟乙基淀粉双取代比例的制备工艺 | |
CN100572387C (zh) | 一种制备2-脱氧-d-葡萄糖的新方法 | |
CN116425709A (zh) | 一种s构型羟丙基四氢吡喃三醇的制备方法 | |
CN102464661A (zh) | 一种5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸乙酯的制备方法 | |
CN112142648B (zh) | 一种米格列醇的制备方法 | |
CN104774161B (zh) | 多肽、蛋白质peg修饰剂合成方法 | |
CN116410161A (zh) | 一种精制呋塞米的方法 | |
CN102464699A (zh) | 一种甘珀酸钠的制备方法 | |
JP3973823B2 (ja) | 多糖類スルホン化体の製造法 | |
CN102336756A (zh) | 美罗培南合成中脱保护基的方法 | |
WO2021109099A1 (zh) | 利用微通道连续流反应器制备 5- 单硝酸异山梨酯的方法 | |
CN110627639A (zh) | 一种酮苯丙氨酸钙的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Building 1, No. 3 Huagongyuan Fourth Road, Huagongyuan Science and Technology Park, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430223 Patentee after: Wuhan University of Science and Technology Life Technology Co.,Ltd. Country or region after: China Address before: 430223 Huagong Science and Technology Park, Daxue Science and Technology Park Road, Donghu Development Zone, Wuhan City, Hubei Province Patentee before: WUHAN HUST LIFE SCIENCE & TECHNOLOGY Co.,Ltd. Country or region before: China |